Showing results (1-10 of 710) with videos related to
Sort By:
Pageof 71
Current Pharmaceutical Design|September 29, 2012
Infections and atheromatous plaque: current therapeutic implicationsMarietta Charakida, Dimitris TousoulisInternational Journal of Cardiology|April 20, 2005
Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failureDimitris Tousoulis, Marietta Charakida, Christodoulos StefanadisInternational Journal of Cardiology|July 19, 2005
Early atherosclerosis in childhood: diagnostic approaches and therapeutic strategiesMarietta Charakida, Dimitris Tousoulis, Christodoulos StefanadisCurrent Opinion in Cardiology|August 10, 2013
Drug treatment of obesity in the cardiovascular patientMarietta Charakida, Dimitris Tousoulis, Nicholas FinerItalian Heart Journal : Official Journal of the Italian Federation of Cardiology|April 15, 2003
The impact of platelet glycoprotein IIIa and Ia polymorphisms in cardiovascular thrombotic diseaseMarietta Charakida, Dimitris Tousoulis, Christodoulos Stefanadis, et al.Current Pharmaceutical Design|December 30, 2011
Inflammatory disorders and atherosclerosis: new therapeutic approachesMarietta Charakida, Frank O'Neil, Stefano Masi, et al.Expert Opinion on Investigational Drugs|March 5, 2016
Celecoxib for the treatment of atherosclerosisNikolaos Papageorgiou, Effimia Zacharia, Alexandros Briasoulis, et al.Pharmacology & Therapeutics|June 16, 2010
Recent therapeutic approaches to platelet activation in coronary artery diseaseDimitris Tousoulis, Ioannis Ph Paroutoglou, Nikolaos Papageorgiou, et al.International Journal of Cardiology|December 19, 2006
Statins in heart failure. Beyond the lipid lowering effectDimitris Tousoulis, Marietta Charakida, Elli Stefanadi, et al.Expert Opinion on Therapeutic Targets|February 9, 2016
HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammationNikolaos Papageorgiou, Effimia Zacharia, Emmanuel Androulakis, et al.Pageof 71